Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$34.94
+$0.11 · +0.32%
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Previous close
$34.94
+$0.11 · +0.32%
Regular session · ET · Market data may be delayed.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Day range
Current $34.94
52-week range
Current $34.94
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Buy
Favorable setup — positive multi-factor alignment
Valuation
71
Undervalued
Sentiment
55
Mixed
Risk
30
Moderate Risk
Momentum
60
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Day range
Current $34.94
52-week range
Current $34.94
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.24B USD | 1.19B USD | 1.09B USD | 901M USD | 791M USD |
| Cost of goods sold | 246M USD | 231M USD | 174M USD | 151M USD | 127M USD |
| Gross profit | 993M USD | 957M USD | 919M USD | 750M USD | 664M USD |
| Research and development | 97M USD | 107M USD | 116M USD | 74M USD | 52M USD |
| Selling, general, and administrative | 634M USD | 618M USD | 569M USD | 469M USD | 431M USD |
| Operating expenses | 728M USD | 925M USD | 1.08B USD | 831M USD | 451M USD |
| Interest income | 22M USD | 23M USD | 43M USD | 19M USD | 4M USD |
| Interest expense | 45M USD | 41M USD | 35M USD | 29M USD | 26M USD |
| Depreciation and amortization | 20M USD | 29M USD | 15M USD | 16M USD | 22M USD |
| Operating income | 265M USD | 32M USD | −156M USD | −81M USD | 213M USD |
| Net income | 210M USD | 2M USD | −129M USD | −44M USD | 205M USD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Limited analyst sample: 4 ratings. Interpret the distribution with caution.
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR289.95M0.26%109.08B USD0.06%$145.34+0.37%
Vanguard Morningstar Total Stock Market ETFVTI155.55M0.01%2.3T USD0.03%$379.73-0.32%
Vanguard Morningstar Small-Cap ETFVB112.17M0.06%183.4B USD0.03%$300.01+0.05%
iShares Russell 2000 ETFIWM105.67M0.13%79.88B USD0.19%$296.01+0.28%
Vanguard Morningstar Small-Cap Growth ETFVBK64.97M0.15%43.8B USD0.05%$349.44+0.01%
Invesco S&P SmallCap Momentum ETFXSMO59.02M1.96%2.99B USD0.35%$85.04+0.73%
Vanguard Extended Market ETFVXF56.16M0.06%93.7B USD0.05%$242.66+0.14%
iShares S&P Small-Cap 600 Growth ETFIJT44.13M0.52%8.19B USD0.18%$170.31+0.14%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap Growth ETFVBKInvesco S&P SmallCap Momentum ETFXSMOVanguard Extended Market ETFVXFiShares S&P Small-Cap 600 Growth ETFIJTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
